- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small-cell Lung in Korea, Democratic People's Republic of
Total 913 results
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Severance HospitalCompletedNK/T-cell Lymphoma of Nasal CavityKorea, Republic of
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Korea University; Yonsei University and other collaboratorsCompletedDiffuse Large B-cell LymphomaKorea, Republic of
-
Seoul National University HospitalGyeongsang National University Hospital; Chungnam National University Hospital and other collaboratorsRecruiting
-
The Catholic University of KoreaActive, not recruitingLymphoma, Large B-Cell, DiffuseKorea, Republic of
-
Chonbuk National University HospitalCompletedLymphoma, Large B-Cell, DiffuseKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung Cancer | Solid Tumors | Castration Resistant Prostate Cancer | Microsatellite Stable Colorectal CancerCanada, United States, Australia, Israel, Korea, Republic of
-
Inje UniversityUnknownNon Hodgkin's LymphomaKorea, Republic of
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedDiffuse Large B-cell Lymphoma (DLBCL)Korea, Republic of
-
Samsung Medical CenterConsortium for Improving Survival of Lymphoma; Lymphoma Study Association; Deok-Hwan... and other collaboratorsCompletedExtranodal NK/T-cell Lymphoma, Nasal TypeKorea, Republic of
-
Samsung Medical CenterCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
PfizerActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Netherlands, Korea, Republic of, Italy
-
Asan Medical CenterJanssen Korea, Ltd., KoreaCompletedLymphoma, B-Cell | Lymphoma, Large-Cell, DiffuseKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National...CompletedExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeKorea, Republic of
-
YM BioSciencesCIMYM BioSciencesTerminatedMetastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Cuba, Pakistan
-
Novartis PharmaceuticalsTerminatedNon-Small-Cell LungGermany, Spain, Belgium, Canada, Netherlands, Italy, Taiwan, Argentina, Australia, Israel, Japan, Lebanon, France, Poland, United States, Jordan, Korea, Republic of, China, Brazil, Czechia, Greece, Russian Federation, Denmark, Hungary, ... and more
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Taiwan, Korea, Republic of, Japan, Spain
-
Hoffmann-La RocheCompletedNon-small Cell Lung CancerBelgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia
-
Chonbuk National University HospitalPusan National University Hospital; Chonnam National University Hospital; Korea... and other collaboratorsCompletedLymphoma, Large B-cell, DiffuseKorea, Republic of
-
Samsung Medical CenterCompletedDiffuse Large B-cell LymphomaKorea, Republic of
-
Samsung Bioepis Co., Ltd.CompletedA Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung CancerLung Cancer | Non-small Cell Lung CancerKorea, Republic of, Germany, Hungary, Taiwan, Thailand, Georgia, Serbia, Poland, Romania, Ukraine, Spain, Belarus, Russian Federation
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Eisai Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Taiwan, Hong Kong, Spain, Poland, Singapore, Russian Federation, Italy, Australia, France, Germany, Japan, United Kingdom, Korea, Republic of
-
Samsung Medical CenterCompletedExtranodal NK/T Cell LymphomaKorea, Republic of
-
Dong-A University HospitalCompleted
-
CelltrionTerminatedDiffuse Large B-Cell LymphomaKorea, Republic of
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
Seoul National University HospitalConsortium for Improving Survival of LymphomaCompletedMantle Cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedMantle Cell LymphomaKorea, Republic of
-
Samsung Medical CenterSeok Jin KimTerminatedMantle Cell LymphomaKorea, Republic of
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, Japan, France, Hungary, Netherlands
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Netherlands, Spain, Belgium, Brazil, Japan, China, Australia, Germany, Argentina, Canada, Czechia, France
-
Samsung Medical CenterMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphoma, Extranodal NK-T-CellKorea, Republic of
-
Chonbuk National University HospitalConsortium for Improving Survival of LymphomaCompletedLarge B Cell Diffuse LymphomaKorea, Republic of
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Italy, France, Japan, Taiwan, Netherlands, Australia, Canada
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
Novartis PharmaceuticalsCompletedNon-Small-Cell Lung CancerGreece, Taiwan, Germany, Belgium, Italy, Spain, United Kingdom, Korea, Republic of, Netherlands, China, Hungary, Poland, France, Thailand, Portugal
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more